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The following excerpt is from an article 
by Joseph A. Carrese and the Members 
of the American Society for Bioethics and 
Humanities Clinical Ethics Consulta-
tion Affairs Standing Committee. HCEC 
Pearls and Pitfalls: Suggested Do’s and 
Don’t’s for Healthcare Ethics Consul-
tants. 
HCEC PEARLS AND PITFALLS 
1. Don’t assume that the question you 
are asked to address is a matter of 
ethics, or that it is the primary issue 
or the only issue. Do take the time to 
clarify for yourself (and your team) the 
following: What are the relevant con-
cerns, and are they a matter of ethics? 
Those requesting an ethics consultation 
recognize that a problem exists. How-
ever, they may not be able to accurately 
determine whether the problem is truly a 
matter of ethics or not, and even if they 
can, they may not be able to correctly 
articulate the precise nature of the ethical 
concerns (that is, the values about which 
there is uncertainty or conflict). Further, 
requesters may not appreciate that, in ad-
dition to the question(s) they have raised, 
other important ethical concerns may be 
involved. One important task for HCECs, 
then, is to determine if the request is 
appropriate for ethics consultation and, 
if so, to clarify the ethical concern(s).1 
If the request does not involve an ethics 
question (that is, what should be done 
in the face of uncertainty or conflict 
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about values), it should be referred to 
other resources in the healthcare system 
that are better equipped to handle such 
requests. For example, if the requester is 
seeking a legal opinion, he or she should 
be referred to legal counsel. Similar to 
making a diagnosis in clinical medicine, 
where precision in diagnosis leads to 
appropriate intervention, clearly and 
accurately identifying and describing the 
ethical concerns in an ethics consulta-
tion will more likely lead to a correct and 
helpful analysis and appropriate recom-
mendations. Another parallel to clinical 
medicine is that, as the case unfolds over 
time, new issues may emerge. An initial 
set of questions, even when addressed 
and resolved, may lead to awareness of 
new ethical issues as the case evolves. 
The consultant should be attentive and 
open to this possibility and revisit the 
ethics question(s) in the consultation, as 
needed. 
2. Don’t conduct ethics consultations 
a different way each time. Do have a 
standardized and systematic approach 
for gathering, analyzing, and synthe-
sizing information. 
“Excellence is an art won by training 
and habituation: we do not act rightly 
because we have virtue or excellence, but 
we rather have these because we have 
acted rightly; . . . we are what we repeat-
edly do. Excellence, then, is not an act 
but a habit.”2 Excellence in ethics consul-
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information and when identifying, 
and, in turn, evaluating, ethically 
acceptable options. One strategy to 
contemplate when considering this 
“Pearl” is to periodically ask oneself 
and others involved in the consulta-
tion the following questions: Have we 
missed anything? Is there anything we 
haven’t considered or anyone from 
whom we haven’t heard? Have we ac-
counted for all relevant perspectives? 
Are we aware of our assumptions and 
have we assessed them? Are there 
other possible explanations for what 
is happening? Have any new issues 
emerged since we started the consulta-
tion? Have we challenged ourselves to 
think creatively to identify additional 
ethically supportable options? 
4. Don’t conduct informal “curb-
side” consultations when making 
recommendations about a specific 
patient. Do conduct formal case 
consultations that are documented 
in the patient’s medical record. 
There are times when physicians 
and nurses ask HCECs for advice 
over the phone or in the hallway and 
there can only be a brief exchange 
of information and ideas. Staff may 
desire a quick answer and may want to 
avoid initiating a consultation process 
that may take some time to complete. 
Forces conspiring to truncate the ethics 
consultation process can, at times, be 
very significant. A concern related to 
quick, curbside consultations is the 
possibility of incomplete appreciation 
by HCECs of all of the relevant facts 
and considerations. This in turn could 
lead to inappropriate or unfounded 
advice. In contrast, a formal, deliberate 
approach to gathering information and 
discussing the issues that have been 
raised enhances the likelihood that the 
process and outcome will be of the 
highest quality. In addition, a tele-
phone or hallway conversation is not 
captured in the medical record, and is 
therefore not available for other mem-
bers of the healthcare team to review 
tation, as in any other pursuit, is not an 
accident. It is borne of commitment, 
training, and the habit of approach-
ing our work with high standards and 
rigor, every single time we do a con-
sultation. One strategy for facilitating 
high quality ethics consultation is to 
have a standardized process for con-
ducting consultation that is thorough, 
systematic, and employed every time. 
Approaching one’s work differently 
each time increases the likelihood of 
omissions and mistakes. Many strate-
gies for conducting healthcare ethics 
consultations have been suggested.3 
We do not endorse a particular strat-
egy; rather, we urge HCECs and con-
sultation services to select and use one 
strategy consistently—that is, to make 
it a habit, so that quality is enhanced 
and excellence can be achieved. 
Another advantage of a consistent 
approach is that, over time, those who 
request assistance from HCECs learn 
what to expect. 
3. Don’t come to premature closure 
about the issues involved and the 
options available. Do take the time 
necessary to be thorough in each 
step of the consultation process. 
One basic rule in clinical medicine 
is resisting the temptation to arrive at 
a conclusion prematurely.4 Instead, 
the preferred approach is to be care-
ful, deliberate, and thorough before 
arriving at a conclusion. The same 
applies to healthcare ethics (HCE) 
consultation. Thoroughness in all 
phases of the consultation process may 
take more time, but this approach is 
more likely to result in sound recom-
mendations. HCE consultants should 
adhere to a systematic approach for 
gathering information (such as one of 
those referenced in Pearl 2) that begins 
with careful chart review (for case 
consultation), proceeds to interview-
ing stakeholders, and includes careful 
reflection along the way. Similarly, 
a thorough approach should be em-
ployed when analyzing the gathered 
Do's and Don't's 
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and reflect upon. A carefully written 
formal consultation note placed in the 
medical record is available to others 
and serves as evidence that important 
issues in the case were carefully con-
sidered by HCE experts. 
However, despite the preference for 
formal consultation, HCECs should be 
sensitive to the needs and limitations 
of those who may desire their services 
but are not willing or able to engage 
in a formal case consultation process. 
Consultants should develop strate-
gies for being responsive, engaged, 
and helpful, even when a formal case 
consultation is not being requested.5 
For example, it is acceptable for 
HCECs to educate and offer generic 
advice to colleagues. An HCEC might 
be asked by a colleague to review 
and explain the key steps in assessing 
decision-making capacity, as a point 
of general information. Similarly, an 
HCEC, before being invited to under-
take a formal case consultation, might 
advise careful communication between 
key stakeholders (such as a meeting 
between staff and family members). 
The key issue here is role clarifica-
tion. There is an important distinction 
between providing general education 
or coaching about communication 
principles and giving specific advice 
about a particular patient that may 
lead to important decisions about that 
patient’s medical care. HCECs need to 
be aware of this distinction, be clear 
about their role, and avoid offering 
specific advice about a particular 
patient unless it is in the context of a 
formal case consultation. 
5. Don’t allow the HCE consulta-
tion discussion to be dominated by 
particular individuals. Do be facili-
tative, inclusive, and a good listener. 
The work of an HCEC, by defini-
tion, involves interaction with multiple 
parties, including patients, family 
members, and staff. Clearly, either in 
one’s role as a member or as a leader 
of a consultation team, it is essential to 
ensure that all perspectives are given 
voice and that all stakeholders feel 
included and respected. If one person 
dominates the conversation, there is 
a risk that important information will 
not be communicated. Attention to 
core dialogue skills such as suspen-
sion of judgment, identification of 
the assumptions being made, skilled 
listening and inquiry, and reflection 
helps to create an inclusive, facilita-
tive process.6 This “ethics facilitation 
approach”7 decreases the likelihood 
of missing crucial information and 
enhances the probability of arriving at 
an optimal understanding of the situa-
tion.8 
6. Don’t assume your written con-
sultation note will be understood 
without verbal communication. Do 
use the consultation as an oppor-
tunity to engage healthcare staff in 
direct conversation to explain and 
teach. 
One basic premise of optimal HCE 
consultation is optimal communica-
tion. Usually this means direct verbal 
communication with members of the 
requesting service to review key rec-
ommendations and associated reason-
ing, in addition to generating a writ-
ten consultation note.9 Direct verbal 
communication increases the likeli-
hood that consult participants will 
understand the specific ethical con-
cerns raised during the consultation, 
in part by creating an opportunity for 
questions to be asked and addressed. 
In this way, direct verbal communica-
tion reduces the risk of confusion or 
misunderstanding. In addition, many 
HCECs consider teaching and educa-
tion to be part of their core mission—
that is, to help those involved learn to 
work through ethical uncertainties and 
disagreements on their own.10 Engag-
ing members of the requesting service 
in conversations throughout the con-
sultation process is one way to fulfill 
the HCEC’s teaching mission. 
7. Don’t assume you are doing 
a good job. Do invite evaluation 
of your consultations from those 
requesting and/or participating in 
them. 
A basic principle of quality im-
provement is to evaluate what you 
are doing. One way to evaluate ethics 
consultation is by getting feedback 
from end users.11 While hard work and 
good intentions are important, they 
alone don’t ensure that HCECs are do-
ing the best job possible. For example, 
ethics consultants have blind spots 
like everyone else: interactions may be 
perceived by others as suboptimal in 
ways that HCECs cannot appreciate. 
Inviting feedback about specific as-
pects of the consultative process from 
those who requested and participated 
in the consultation is a useful way to 
better understand what is going well 
and what needs attention and improve-
ment. The Department of Veterans 
Affairs Integrated Ethics initiative 
has many useful resources, including 
an evaluation tool that can be used 
to assess participants’ perceptions of 
consultation performance.12 Using this 
tool or a similar evaluation instrument 
after every consultation, combined 
with periodic review and discussion 
of aggregated feedback results, is an 
important step toward making neces-
sary adjustments and providing better 
ethics consultation services. Examples 
of domains about which HCECs might 
invite feedback include respecting the 
opinions of the requestor, giving use-
ful information, explaining effectively, 
clarifying decisions to be made, clari-
fying appropriate decision makers, 
identifying and describing ethically 
supportable options, and being acces-
sible and timely. 
8. Don’t assume that everyone who 
needs an ethics consultation will 
know that they need one, or even 
know that a consultation service ex-
ists. Do engage in outreach to raise 
awareness about the existence and 
role of the HCE consultation service. 
Fox and colleagues found that 80 
percent of U.S. hospitals and 100 
percent of hospitals with 400 or more 
beds have an ethics consultation 
Cont. on page 4
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service.13 However, patients, family 
members, and members of the hospital 
community who may be involved in 
patient care and who may be in a posi-
tion to request an ethics consultation 
may not be aware that a consultation 
is needed, or they may not be aware of 
the existence of the HCE consultation 
service as a valuable resource. Lack of 
awareness that an ethics consultation 
is needed could be addressed by infor-
mational and educational outreach in 
a variety of forums in both the com-
munity and in the healthcare facility. 
The goal of these efforts should be to 
increase understanding about clinical 
ethics concerns and raise awareness 
about the HCE consultation service 
as a resource for addressing these 
concerns. HCECs should be mindful 
of how they describe and market the 
ethics consultation service to avoid the 
common misconception that request-
ing an “ethics consultation” means that 
someone has done something “unethi-
cal.” In this regard, it may be more 
useful and less threatening to describe 
an ethics consultation as a way of 
protecting a “moral space” for staff to 
reflect on complex issues.14 
9. Don’t assume that everyone who 
wants an ethics consultation will feel 
empowered to ask for one. Do take 
action to reduce barriers to consul-
tation requests. 
Individuals who may be in a posi-
tion to request an ethics consultation 
may not feel empowered to request 
one. Lack of empowerment among 
healthcare providers to request a 
consultation may occur for a variety 
of reasons, including a suboptimal 
work environment, suboptimal rela-
tionships with colleagues, or fear of 
retribution for “rocking the boat” or 
“whistle-blowing.” Some of these 
potential reasons may be related to a 
staff member’s location in the orga-
nizational hierarchy.15 An unfortunate 
consequence of this situation is that 
moral distress is often suffered by staff 
members who believe that request-
ing an ethics consultation is the right 
thing to do, yet who feel uncomfort-
able requesting a consultation, either 
because the risks are too high or they 
are actively prevented from doing 
so.16 Lack of empowerment among 
patients or family members to request 
a consultation may relate to fears of 
offending members of the healthcare 
team. Strategies for addressing these 
barriers include clear institutional 
policies and procedures asserting open 
access to HCE consultation;17 and 
ongoing outreach and education by 
HCECs. Education should be directed 
toward staff, who may desire an ethics 
consultation but who are not able or 
willing to request one over and against 
resistance by others, and those who 
are likely to be resisting a consulta-
tion request in the first place. Attention 
should be paid to how the service is 
described and marketed, as mentioned 
in Pearl 8. 
10. Don’t confuse legal consider-
ations with HCE consultation. Do 
recognize the appropriate roles and 
contributions of legal considerations 
in HCE consultation. 
While legal considerations (includ-
ing risk management and legal prec-
edent) and ethical concerns related to 
a particular case may overlap con-
siderably, they are not synonymous. 
This is not surprising, because their 
ultimate purposes differ, and the key 
stakeholders may be different. For 
example, in risk management, one 
goal is institutional protection, and the 
key stakeholder is typically the institu-
tion itself. For HCE consultation, the 
ultimate goal is arriving at healthcare 
decisions that are ethically optimal and 
defensible, and the key stakeholder 
(particularly in a case consultation) is 
typically a person, such as a patient or 
a staff member. Similarly, while legal 
considerations (such as case law or 
relevant state/federal legislation) may 
be very germane and inform ethical 
thinking about a case in important 
ways, what legal counsel might advise 
may differ from what the HCEC might 
recommend. Accordingly, the HCEC 
must resist the temptation to simply 
follow the guidance of legal counsel 
or risk managers, and instead arrive 
independently at positions and recom-
mendations based on ethical principles 
and considerations. 
11. Don’t be too sure of yourself. Do 
embrace the complexity of each case 
with a healthy dose of humility. 
Humility in an ethics consultant 
is a desirable, if not necessary, trait. 
Important features of humility are self-
awareness, careful reflection, and a re-
spectful attitude towards others. There 
are many reasons to embrace humility: 
the absence of a clear, right answer; 
the uncertainty often present in clinical 
medicine that permeates many cases 
for which HCE consultations are 
requested; the fact that reasonable 
people can and often do disagree about 
how to regard the same set of facts; 
the reality that consultants’ abilities to 
know and understand are limited and 
imperfect. In addition, humility may 
have the added value of positioning 
a consultant to be open to and even 
actively seek alternative perspectives, 
which may lead to a more complete 
process, and ultimately to better con-
sultations. Finally, humility may help 
consultants appreciate the boundaries 
of their role and serve as a check to 
overstepping their authority during a 
consultation.18 Humility, therefore, is 
the proper disposition of consultants. 
12. Don’t do it all on a shoestring. 
Do advocate for adequate resources 
and support for yourself and your 
fellow consultants. 
In an era when most of us are ac-
countable to someone for how we 
spend our time, and for how our time 
is supported, securing adequate re-
sources for the important work we do 
is essential. Otherwise, the risk is that 
the time we are able to spend on this 
work is shortchanged, and the goal of 
conducting high quality consultations 
is threatened. There are many aspects 
of HCECs’ work that could benefit 
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from financial support. A partial list 
includes: continuing education related 
to ethics consultation, and to clini-
cal ethics more broadly, for members 
of the consultation team; educational 
sessions provided by the institu-
tion’s HCEC(s) for staff and for the 
greater community; compensation for 
time spent doing HCE consultations. 
HCECs should establish effective 
working relationships with institution-
al administrators to address the issue 
of adequate support for their work, 
broadly defined. 
The full text of this article is avail-
able in the Journal of Clinical Eth-
ics, Fall 2012, volume 23, number 
3, pages 234-240. For permission 
to alter this document in any way, 
contact Joseph Carrese at jcarrese@
jhmi.edu).
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FEATURED WEBSITES
MARYLAND MOLST 
http://marylandmolst.org/
The Maryland Medical Orders for Life-Sustaining Therapy 
(MOLST) website is dedicated to educating patients and 
health care professionals about the MOLST form. It con-
tains information for consumers and health care profession-
als about the purpose of the form, how to complete it, and 
how it should be used to assist in end-of-life care. Readers 
can also view a list of future train-the-trainer sessions.
The final Maryland MOLST regulations and form became 
effective on January 1, 2013. Beginning July 1, 2013, 
certain facilities will be mandated to complete the form for 
certain patients, including nursing homes, assisted living 
facilities, home health agencies, hospices, dialysis centers, 
and hospitals.
  
ONCOTALK 
http://depts.washington.edu/oncotalk/
The Oncotalk website is directed toward oncologists and 
oncology fellows, but is relevant to anyone who wishes to 
improve their knowledge and skills related to communica-
tion at the end of life. Oncotalk faculty include Tony Back, 
MD, Bob Arnold, MD, Walter Bailey, MD, James Tulsky, 
MD and Kelly Fryer-Edwards, MA PhD. The faculty have 
prepared the following downloadable learning modules:
• Introduction to Oncotalk Teach
• Roadmap for a successful teaching encounter
• Setting useful learning goals
• Balancing your commitments to patient & fellow
• Using yourself as a role model
• Feedback that engages fellows
• Closing: Take-home messages that resonate
• Facilitating group learning
• How learners progress
For each topic, there is a background, "how to do it", pearls 
and pitfalls, and a few key references. The “Tough Talk” 
section helps clinicians approach difficult conversations 
with patients, with a host of tools for both learners and 
teachers, including short video clips demonstrating com-
munication techniques.
The Oncotalk website and materials, funded through a 
Greenwall Foundation grant, were developed as part of the 
Oncotalk training program for Oncology Fellows, which 
was funded by the National Cancer Institute. 
In this section, we highlight two websites that may be useful resources for ethics committees.
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY FROM A MARY-
LAND HOSPITAL & NURSING 
HOME
Mrs. K was 101 years old. She 
enjoyed robust health throughout 
her life, but experienced progressive 
cognitive and functional impairment 
over the last 12 years. She lived with 
her son’s family. Shortly after her 
101st birthday, Mrs. K developed 
lung congestion and lethargy and was 
taken to an academic teaching hospi-
tal. She had no advance directives or 
any documented conversation with a 
health care provider about her end-
of-life wishes. The physicians asked 
her son what should be done in the 
event of a cardiac arrest. Her son took 
some offense at the question and said, 
“I want you to do everything for my 
mother.” As the physicians explained 
what cardiac resuscitation meant in 
more detail, he became indignant. “So 
if a young person has a cardiac arrest, 
you try to save her. But with an old 
person, you wouldn’t even try? You 
would just let her die?! You need to do 
everything for my mom. She deserves 
the best.”
After two days in the hospital for 
treatment of aspiration pneumonia, 
Mrs. K became more congested and 
developed respiratory failure. Because 
of her “full code” status, she was 
intubated and placed on mechanical 
ventilation. She developed multiple 
complications. She was agitated and 
received sedation. When the seda-
tion was discontinued, however, she 
did not regain consciousness. She did 
not respond well to weaning trials, so Cont. on page 8
a tracheostomy was performed. She 
could not eat, so clinicians inserted a 
feeding gastrostomy tube. She de-
veloped a sacral decubitus ulcer, and 
had a Foley catheter in place. On the 
27th day of hospitalization, she was 
transferred to a nursing facility near 
hre son’s home, on the mechanical 
ventilator.
The attending physician at the 
nursing facility found that Mrs. K 
could open her eyes in response to 
verbal or tactile stimulation, but she 
did not track and did not respond 
to visual threat. She did not make 
spontaneous purposeful movements. 
She withdrew from painful stimuli 
and grimaced when suctioned. She did 
initiate breaths, but had visible signs 
of distress with trials of weaning from 
the ventilator. Her large stage 4 sacral 
wound was clean and her gastrostomy 
tube was functioning well. Her vital 
signs were stable. She was transferred 
from the hospital as a full code status 
patient. Upon nursing home admis-
sion, when reviewing the options in 
the Medical Orders for Life-sustaining 
Treatment (MOLST) form with the 
team, her son insisted that “everything 
be done” to keep his mother alive. The 
nursing facility attending physician 
and medical director notified him that 
cardio-pulmonary resuscitation (CPR) 
would not be attempted in the event of 
a cardiac arrest at the facility, because 
it would be medically ineffective. The 
son was taken aback by this, asking, 
“If CPR were medically ineffec-
tive, why didn’t they tell me that at 
the hospital?” An ethics consult was 
requested to discuss the topic of medi-
cal ineffectiveness and to consider 
what constituted ethically appropriate 
treatment options for this 101 year-old 
woman.
COMMENTS FROM A PHYSI-
CIAN & NURSING FACILITY 
MEDICAL DIRECTOR 
As more members of our society 
live past 100 years of age, the goals 
of medicine in an aging society are 
called into question. There are more 
centenarians alive today than in any 
other time of human history. The 
United States leads the world with the 
greatest number of centenarians, with 
Japan close behind. The 1950 U.S. 
census identified 4,440 centenarians in 
the United States. The number rose to 
10,369 in the 1960 census, 32,194 by 
1980 and 53,364 by 2010 (Knach & 
Velkoff, 1999; Werner, 2010). Of those 
who reach their 100th birthday, about 
one in 10 will reach their 105th birth-
day, and one in 1,000 will reach their 
110th birthday. Approximately one in 
10,000 persons in the U.S. today are 
expected to live to be 100, while only 
one in five million are expected to live 
to be 110. The longest documented hu-
man life span was a woman who lived 
122 years and died in 1997. Eighty 
percent of centenarians are women. 
The burden of disability is very high in 
the centenarian population, with about 
80% experiencing cognitive impair-
ment, and less than 20% reporting no 
significant functional impairment. Half 
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of all centenarians in the U.S. live in 
nursing facilities (Perls, 2004). 
In the absence of advance direc-
tives, the most important information 
in guiding medical decision making 
for the 101 year-old woman in the 
case study should have been her health 
trajectory prior to her hospitalization. 
Regardless of age, a person with a 
decade long history of a progressive 
dementing illness that has resulted in 
functional dependency, incontinence, 
dysphagia, and weight loss has en-
tered a period of terminal decline. 
The episode of aspiration pneumonia 
with respiratory failure is an expected 
event in the terminal trajectory of 
dementia. The physiologic reserves 
in a centenarian are diminished and 
are not able to withstand or rebound 
from such an event. When the son 
asked for “everything” to be done for 
his mother, the physician should have 
explained to him that all appropriate 
and effective interventions would be 
performed. Procedures that would 
simply prolong the dying process 
should not be performed, since they 
would not provide benefit to the pa-
tient. They would not restore health. 
A patient with this person’s history 
should not have been intubated and 
supported on mechanical ventilation, 
because respiratory failure was an 
expected part of her terminal illness. 
The support of mechanical ventilation 
would not be expected to change her 
outcome, other than to prolong an in-
evitable dying process and contribute 
to unnecessary suffering on the part of 
the patient. It is also not a justifiable 
use of health care resources. A decade 
ago the question was whether every 
person with dementia had to die with 
a gastrostomy tube in place. A consen-
sus emerged over the past decade that 
demented patients do not benefit from  
gastrostomy tubes at the end of their 
lives. Therefore their use in demented 
patients with a terminal trajectory gen-
erally is not recommended (Finucane, 
Christmas & Travis, 1999). Today the 
discussion is whether every end-stage 
dementia patient dying of pneumonia 
must receive mechanical ventilation 
when the family requests that “every-
thing be done.” 
The primary care physician had a 
duty to this patient and her family to 
discuss the typical progression and 
outcome of her illness long before 
she presented to the hospital with her 
acute illness. There were no advance 
directives, however, and no history 
of any such discussions having taken 
place prior to the acute event. In one 
study, health care proxies of demented 
patients who were presented prognos-
tic data and understood the clinical 
complications expected in advanced 
dementia were less likely to undergo 
burdensome interventions during the 
final three months of life. And yet only 
18% of the health proxies in the study 
stated they had received any prog-
nostic information from a physician 
(Mitchell, et al., 2009). Physicians 
may not feel capable or confident in 
presenting prognostic estimates to pa-
tients. Prognostic tools are now avail-
able online at www.eprognosis.com to 
help physicians estimate prognosis for 
elderly patients in various settings and 
with various clinical conditions. 
Physicians in all settings shy away 
from considering and implementing 
the concept of medical ineffectiveness. 
Perhaps some physicians feel that 
talking about death is a form of elder 
abuse. Breaking through our deep 
cultural denial of death, telling our 
patients “memento mori” (“remember 
you must die”) may seem to some 
as unkind. However, it is a greater 
disservice to older adult patients not 
to ask about their end-of-life prefer-
ences when they are still able to state 
their opinions. Older adults generally 
have more realistic expectations about 
dying than do their adult children. 
Physicians may fear being a target for 
a lawsuit if they do not do the fam-
ily’s bidding in the absence of advance 
directives. Avoidance of dealing with 
hard issues in the name of fear, how-
ever, is nothing more than cowardice. 
In Atul Gwande’s brave new world 
of “Cheesecake Factory Medicine” 
(2012), if physicians are simply taking 
the family member’s “order,” without 
assessing the effectiveness or appro-
priateness of the intervention, they are 
reduced to the role of simply being a 
“wait staff.” In some settings it is the 
risk managers who may override the 
physicians and ethics committee and 
tell physicians, “Do whatever the fam-
ily says and wants,” since the hospital 
does not want to face the threat of a 
potential law suit from a disgruntled 
family member. Within a fee-for-
service environment, although there 
may be a moral imperative to discuss 
prognosis and medical ineffectiveness, 
there is a profound financial incentive 
not to do so, for both the physician and 
the hospital. While medically ineffec-
tive treatment and care may be offered 
as the path of least resistance with a 
family, the arrival of global budgeting 
will create a new battleground, as the 
provision of ineffective medical inter-
ventions may not be considered an ac-
ceptable expense. It will be interesting 
to watch the dynamics of global bud-
geting on clinical decision-making at 
the bedside. If physicians are rewarded 
for “cost effective” practice, there may 
be a not-so-subtle conflict when invok-
ing the withholding of interventions 
due to medical ineffectiveness. Global 
budgeting may further the distrust that 
already exists between some family 
members and the treating physicians.
Should otherwise healthy, non-
demented 101 year-old persons with 
pneumonia and respiratory failure 
have a trial of intubation and me-
chanical ventilation? If it could benefit 
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them, the answer should be yes. But 
the change to global budgeting might 
deny such a person that opportunity 
in the name of medical ineffective-
ness based upon advanced age alone. 
The physicians in the case presented 
should have looked to the pre-hospi-
talization trajectory of illness to guide 
their prognostication and determina-
tion of an ethically appropriate plan of 
care for this patient.
Medical effectiveness or ineffective-
ness of various interventions can de-
pend not only on the specific interven-
tion, but also on the site in which it is 
being provided. The term “CPR” has 
many different levels of meaning. For 
example, if the standard of care in the 
nursing facility for CPR is to provide 
basic life support [with or without 
an automated external defibrillator 
(AED)] and call 911, CPR attempts 
would be expected to have a much 
lower rate of effectiveness than CPR 
efforts for a patient in an emergency 
department or intensive care unit in 
a hospital. In a nursing facility, most 
cardiac arrests are unwitnessed. When 
CPR is instituted, it is often performed 
on patients who have been dead for an 
undetermined amount of time. CPR 
is most effective when it is performed 
immediately in a witnessed arrest, in a 
monitored patient with full advanced 
cardiac life support capacity readily 
available. Patients within intensive 
care units may request administration 
of medication for cardiac arrhythmia 
but no electro-cardioversion. They 
may request attempts at cardioversion 
without intubation. The new Medical 
Orders for Life Sustaining Treatment 
(MOLST) form process does not take 
these distinctions into account. Al-
though the MOLST is intended to be 
valid across sites of care, “code status” 
and health care preferences should 
be re-evaluated at every transition 
of care, to validate the preferences 
outlined at the preceding site of care, 
and to translate those preferences into 
appropriate and site-specific effective 
interventions.
The goals of medicine in an aging 
society should be to promote health 
and to prevent premature mortality 
(Callahan, 1987). The question of how 
to determine what mortality is prema-
ture is often problematic. The Centers 
for Disease Control has historically 
categorized premature mortality as 
that occurring prior to age 65. The 
deaths of some people dying even 
after the age of 100, however, could be 
categorized as premature. The goals of 
medicine for centenarians should be to 
promote health, to preserve function, 
to cure acute illness when possible, 
and to relieve suffering. An essential 
goal of medicine in an aging society 
is to be able to recognize a terminal 
trajectory. Once a person has entered 
the terminal trajectory, the goal of 
medicine should be to relieve suffering 
and to refrain from providing burden-
some interventions that will only serve 
to prolong the dying process. 
Rebecca D. Elon, MD, MPH
Associate Professor of Medicine
Johns Hopkins University School of 
Medicine
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COMMENTS FROM A NURSE 
ETHICS CONSULTANT 
The ethical issues at the center of 
this case stem from the following 
systemic failures in our health care 
system: 
1. to provide high-quality palliative 
end-of-life (EOL) care through-
out the disease trajectory.
2. to adequately educate individu-
als and communicate with them 
about end-of-life (EOL) care, 
and to document an individual’s 
EOL preferences so these are 
readily accessible when needed.
3. to define an appropriate medical 
standard of care at the end of life 
and treat like cases alike across 
health care delivery settings.
4. to acknowledge that being a 
good steward of limited health 
care resources must involve 
decisions made by healthcare 
providers at the bedside.
When a patient has received excel-
lent palliative care and has participated 
in good EOL care planning, it’s less 
likely that withholding or withdrawing 
interventions against the patient’s or 
surrogate’s wishes based on medically 
ineffective or non-beneficial treatment 
criteria comes up. The latter may cre-
ate distrust or animosity between the 
staff and the patient/surrogate that can 
complicate the dying and bereavement 
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process, so efforts should be made to 
avoid adversarial standoffs. Health 
care providers can usually avoid this 
by planning ahead to identify when 
the main goal of care will shift from 
cure to comfort, and by supporting 
loved ones along the way. When that 
happens, patients/surrogates usu-
ally recognize when it’s time to shift 
from “doing everything” to keep the 
patient alive to “doing everything” to 
maximize the quality of the patient’s 
remaining time. Minimizing emotional 
burden and addressing the psycho-
spiritual hurdles that are often a part 
of the dying process for patients and 
loved ones is an appropriate goal of 
medicine because how individuals 
experience the death of someone they 
love can have a long-lasting impact on 
their future well-being. 
The ethics consultant(s) should 
explore whether anyone has informa-
tion about Mrs. K’s wishes, regard-
less of the absence of documentation 
of EOL preferences. It would be the 
rare 101 year old who, if she had the 
cognitive ability, did not ponder her 
own mortality. I recall a conversation 
with one centenarian who pointed out 
that death became less of a threat the 
older she got because “there’s less 
life to miss out on.” Yet, centenarians 
like Mrs. K may also be cherished 
family matriarchs whom others hold 
onto dearly as stalwart branches of a 
deeply-rooted family tree. They are 
survivors who have beat the odds, 
and as such, should not be “given up 
on.” Yet, family members may also 
fall prey to the pitfall of their own 
emotions clouding their judgment of 
what the patient would want, or what 
would be in the patient’s best interests. 
They may demand that “everything be 
done” to keep the patient alive for the 
wrong reasons. Focusing the discus-
sion on what the patient would want 
can help family members avoid feeling 
like they are being asked to “choose 
death” for their loved one.
Unfortunately, acute care medicine 
complicates the task of family mem-
bers sorting through these complex 
emotions by failing to draw bright 
lines between what can be done and 
what should be done medically. Let’s 
assume we don’t, and can’t, know 
what Mrs. K wants. Although Mrs. K’s 
son believes his mother would want to 
continue all life-prolonging treatments, 
including CPR attempts, without any 
evidence of her wishes, the question, 
then, is whether doing so is in Mrs. 
K’s best interests. 
An individual patient’s best inter-
ests are determined by calculating the 
likelihood of achieving an appropriate 
goal from a particular treatment plan 
and whether the burden of treatment 
is tolerable. “Appropriate goals” are 
those that fall within the medical 
standard of care. Low-burden inter-
ventions that are likely to achieve a 
desired goal (e.g., antibiotics to treat 
a painful urinary tract infection) may 
easily pass the test of acceptability. 
High-burden interventions that are 
unlikely to achieve a desired goal 
(e.g., treatment in an intensive care 
unit [ICU] to return an actively dying 
patient to pre-ICU functional status) 
may readily be deemed unacceptable. 
But burden is subjective. For example, 
some consider CPR attempts in per-
sons with advanced co-morbidities to 
be a high-burden intervention due to 
the assault-like nature of chest-com-
pressions and the possibility of break-
ing ribs, while others consider this to 
be a low-burden intervention because 
the patient in cardiopulmonary arrest 
is unconscious and thus can’t “suffer.” 
Burden notwithstanding, many ques-
tion whether prolonging life, in itself, 
is an appropriate goal of medicine, 
particularly when a patient has reached 
her final days or weeks of life. 
Life-prolonging medical interven-
tions are most often limited at the end 
of life by acute care triage practices, 
such as allocating ICU beds and equip-
ment. But there is considerable varia-
tion from one health care facility to the 
next in what types of medical technol-
ogy is offered to patients considered 
“terminal.” The challenge is in know-
ing when a patient is dying and can no 
longer benefit from high-tech medical 
interventions. Clinicians sometimes 
argue that if a patient like Mrs. K can 
be “kept alive with machines,” she’s 
not “dying.” At the age of 101, with 
over a decade of progressive decline 
preceding her 100th birthday, and an 
inability to breathe or eat on her own, 
there should not be such ambiguity 
among clinicians as to whether Mrs. 
K is dying. This ambiguity confuses 
family members. Was Mrs. K’s son 
simply asked if he wanted to “keep his 
mother alive”? Or was he told that his 
mother was dying, and asked how staff 
could best support his mom and family 
through that process? 
We can and should work to avoid 
ethical conflicts by better educat-
ing individuals about EOL care and 
making individuals’ EOL prefer-
ences available through accessible 
and up-to-date advance directives and 
properly-executed MOLST forms. But 
this alone won’t solve the problem of 
high-burden, low-benefit interventions 
at the end of life diverting health care 
resources from others who are more 
likely to benefit. While a “rational 
rationing” plan needs to happen at the 
societal level, providers at the bedside 
are also obligated to use limited re-
sources wisely, and ethics consultants 
should be prepared to assist with these 
considerations (Stretch, Hurst & Dan-
is, 2010). As Sheehan (2003) stated, 
“Providing expensive medical therapy 
with a curative or life-sustaining intent 
when a person is incurable and dy-
ing is arguably unjust in squandering 
resources that are needed elsewhere.” 
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How can this be done ethically? In 
1991, the American Thoracic Soci-
ety (ATS) opined that, “[b]ased on 
the ethical principles of beneficence 
and nonmaleficence, the purpose of a 
life-sustaining treatment should be to 
restore or maintain a patient’s well be-
ing.” In 1997, the ethics committee of 
the Society of Critical Care Medicine 
(SCCM, 1997) concluded that “[t]reat-
ments should be defined as futile only 
when they will not accomplish their 
intended goal. Treatments that are 
extremely unlikely to be beneficial, are 
extremely costly, or are of uncertain 
benefit may be considered inappropri-
ate and hence inadvisable, but should 
not be labeled futile.” SCCM’s ethics 
committee advised using a rationale in 
such cases that is “explicit, equitable, 
and democratic; that does not disad-
vantage the disabled, poor, or unin-
sured; and that recognizes the diversity 
of individual values and goals.” (See 
box above.) 
In Maryland, medical interventions 
may be withdrawn or withheld if they 
are considered “medically ineffective” 
or “ethically inappropriate.” Maryland 
law defines medical ineffectiveness as: 
“… to a reasonable degree of medical 
certainty, a medical procedure will not 
prevent or reduce the deterioration of 
the health of an individual or prevent 
the impending death of an individual.” 
Clinicians would have to determine 
whether the ventilator or feeding tube 
(or dialysis, in the case of kidney shut-
down) met this definition for Mrs. K. 
CPR attempts would meet the defini-
tion, based on Mrs. K's constellation 
of co-morbidities, together with her 
advanced age.* 
Addressing goals of care with excel-
lent palliative care and communication 
handles most of the cases. We are far 
from achieving this level of excellence 
and thus need to improve on this front. 
But for those who believe that “pro-
longing life, regardless of its quality 
or treatment burden, is a worthwhile 
goal,” we lack a valid rationale for 
denying high-burden treatments if we 
insist that distributive justice does not 
come into play. Our zeal to avoid this 
potential conflict of interest further 
confounds the issue because we do 
not openly discuss the role of resource 
stewardship with patients and family 
members. As the Affordable Care Act 
provides more Americans with health 
care coverage, we will be better posi-
tioned to address this openly and fairly 
(Danis, 2012; Donley & Danis, 2012; 
Stretch & Danis, 2012).
So, here we are with Mrs. K and 
her son in the nursing home, trying 
to figure out the most compassionate 
and ethically appropriate way to pro-
vide her care, given all the systemic 
failures presented. Unless evidence 
can be revealed that she would not 
want to continue on life support, the 
“middle ground” of “no escalation 
of treatment” appears to be a valid 
compromise, given the complicity of 
the medical system in getting her to 
this point of dependency on machines 
during her dying process. This would 
allow for continued ventilator and 
feeding tube use until deemed medi-
cally ineffective, but no additional 
high-burden treatments such as CPR 
attempts, dialysis, or ICU transfer. 
In cases like these, the nursing home 
staff should provide the same comfort 
measures as they would for any dying 
patient (see box on p. 12). 
In short, staff should focus on what 
will be done for Mrs. K and her fam-
ily, rather than what won’t be done. 
However, clinicians should make clear 
recommendations to the son (includ-
ing a recommendation to withdraw life 
support and focus mainly on comfort 
care), rather than offering a “platter 
of choices” to the son. The fact that 
Mrs. K had many prior encounters 
with health care providers, but none 
of them documented a conversation 
about end-of-life preferences, speaks 
to a bigger issue that needs prompt 
attention. The ethics consultant(s) 
should follow up in some way on this, 
Cont. on page 12
CRITERIA SUGGESTED BY THE SOCIETY FOR CRITICAL CARE MEDICINE FOR POLICIES TO 
LIMIT INADVISABLE TREATMENT 
• Disclosure in the public record
• Reflection of moral values acceptable to the community
• Avoidance of an exclusive basis on prognostic scoring systems
• Provision of appeal mechanisms
• Recognition by the courts. 
• Recognition by payers that they should formally address criteria for determining when treatments are inad-
visable and should share accountability for those decisions.   
Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other pos-
sibly inadvisable treatments (1997). Crit Care Med,  25, 887-891.
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in an effort toward addressing the 
systemic failures contributing to cases 
like these. 
Anita J. Tarzian, PhD, RN
Ethics & Research Consultant; 
MHECN Program Coordinator
Associate Professor, University of 
Maryland School of Nursing
*If two of Mrs. K’s physicians certi-
fied that CPR, or any other medical 
intervention, would be medically inef-
fective or ethically inappropriate, they 
could withhold or withdraw it after 
informing the daughter of the option 
for transfer. If the daughter requested 
a transfer, the Health Care Deci-
sions Act requires that life-sustaining 
interventions be maintained while 
awaiting transfer. However, this need 
not include CPR attempts, based on an 
interpretation that attempted resuscita-
tion would be ineffective in prolong-
ing Mrs. K’s life. 
REFERENCES
American Thoracity Society (1991). 
Witholding and withdrawing life sus-
taining therapy. American Review of 
Respiratory Diseases, 144, 726-731.
Arnold, B. (February, 2011). What to 
do after the patient is made comfort 
measures only (CMO)  Pallimed case 
conferences, 11(2). Available at http://
cases.pallimed.org/2011/03/what-to-do-
after-patient-is-made.html .
Danis, M. (2012). Thorny questions on 
the way to disclosing rationing. Crit 
Care Med, 40(1), 347-8.
Donley, G., Danis, M. (2011). Making 
the case for talking to patients about the 
costs of end-of-life care. J Law Med 
Ethics, 39(2), 183-93.
Ethics Committee of the Society of 
Critical Care Medicine. (1997). Consen-
sus statement of the Society of Critical 
Care Medicine’s Ethics Committee 
regarding futile and other possibly inad-
visable treatments. Crit Care Med, 25, 
887-891. 
Sheehan, M.N. (2003). Disabilities and 
aging. Theoretical Medicine & Bioeth-
ics, 24(6), 525-33.
Strech, D., Danis, M. (2012). How can 
bedside rationing be justified despite 
coexisting inefficiency? The need for 
'benchmarks of efficiency'. Journal of 
Medical Ethics.
Strech, D., Hurst, S., Danis, M. (2010). 
The role of ethics committees and ethics 
consultation in allocation decisions: a 
4-stage process. Med Care, 48(9), 821-
6.
CARE OWED TO DYING PATIENTS 
• Make sure the patient’s symptoms are adequately treated/prevented.
• Offer the family information about what they are likely to see as their loved one dies.
• Address any religious traditions that are important to the patient/family.
• Encourage the family to invite loved ones to say goodbye to the patient.
• Discuss options for where the patient may spend her final days (e.g., in nursing home with or without hos-
pice support, or transfer to hospice if possible).  
Arnold, B. (February, 2011). What to do after the patient is made comfort measures only (CMO)  Pallimed case 
conferences, 11(2). Available at http://cases.pallimed.org/2011/03/what-to-do-after-patient-is-made.html.
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CALENDAR OF EVENTS
FEBRUARY
21-22 
Empirical Bioethics: Emerging Trends for the 21st Century. Sponsored by the Center for Clinical and Translational Science 
and Training. Kingsgate Marriott Conference Hotel, Cincinnati, OH. For more information, contact Bettie Durant at bettie.
durant@cchmc.org, 513.803.2610.
27 (8:30-10AM) 
What is Wrong with Markets to Obtain Organs for Transplantation? Public Lecture by Art Caplan, sponsored by the Center 
for Bioethics, New York University, New York, NY. Translational Building, 227 East 30th St. (between 2nd and 3rd Ave). 
6th Floor, Conference room 619. For more information, visit http://bioethics.as.nyu.edu/page/events. 
MARCH
7 
Henrietta Lacks Symposium: The Dignity of Difference. Sponsored by the University of Maryland, University of Maryland 
SMC Center and University of Maryland School of Nursing, 621 W. Lombard St., Baltimore, MD. For more information, 
visit www.umm.edu/hela.
8 
Helping Grieving Children and Families. Presenter: Sarah Montgomery, LCSW-C, Coordinator of Children and Family 
Programs. Sponsored by Chesapeake Life Center. Baltimore – Living Legacy Foundation, 1730 Twin Springs Road, Suite 
200, Baltimore, MD. For more information, visit chesapeakelifecenter.org.
14 (7 PM) 
Tenth Annual John Collins Harvey Lecture. Speaker: Daniel Sulmasy, MD, PhD, Kilbride Clinton Professor of Medicine 
and Ethics and Associate Director of the MaClean Center for Clinical Medical Ethics at the University of Chicago. Spon-
sored by Georgetown University’s Center for Bioethics. Salon H of the Leavey Conference Center on the Georgetown 
Campus,Washington, DC. For more information, contact Marti Patchell at patchelm@georgetown.edu.
14-16 
First Annual Professional Skills Program in Dispute Resolution, sponsored by the Center for Dispute Resolution at the 
University of Maryland School of Law (C-DRUM), in partnership with the Straus Institute for Dispute Resolution at Pep-
perdine University. University of Maryland King Carey School of Law, Baltimore, MD. For more information, visit http://
www.law.umaryland.edu/faculty/conferences/.
14-16 
9th International Congress on Clinical Ethics Consultation. Munich, Germany. For more information, visit www.iccec2013.
de.
15 
Facts of Illness/Acts of Profession: Edmund Pellegrino and the Ethics of Health Care. Sponsored by Georgetown Uni-
versity Medical Center’s Center for Clinical Bioethics, Salon G of the Leavey Conference Center on the Georgetown 
Campus,Washington, DC. For more information, contact Marti Patchell at patchelm@georgetown.edu.
15 
Helping Grieving Children and Families. Presenter: Sarah Montgomery, LCSW-C, Coordinator of Children and Family 
Programs. Sponsored by Chesapeake Life Center. Baltimore – Grassroots Crisis Intervention, 6700 Freetown Road, Co-
lumbia, MD. For more information, visit chesapeakelifecenter.org.
20 
Creating Dignified Dialogue: The Role of Health Care Professionals in Ethical Decisions at the End of Life. Presenters: 
Shahid Aziz, MD, Medical Director for Adults and Pediatrics at Hospice of the Chesapeake, & Karen Frank, RN MS, 
CHTP, Director of Chesapeake Life Center. Sponsored by Chesapeake Life Center, 445 Defense Highway, Annapolis, MD. 
For more information, visit chesapeakelifecenter.org.
21-22 
Cultivating Ethical Awareness: Moments of Truth. Second Ethics of Caring National Nursing Ethics Conference. Universal 
Hilton Hotel, Los Angeles, California. For more information, visit http://ethicsofcaring.org.
21-22 
The Politics of Caring:  Ethical Issues of Distributive Justice in an Era of Scarce Resources. Sponsored by Emory Univer-
sity’s Center for Ethics and the Health Care Ethics Consortium of Georgia (HCECG). Atlanta, Georgia. For more informa-
tion, visit www.hcecg.org.
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MARCH (cont'd) 
22 
Digital Ethics: The Impact of Electronic Communications and Social Media on Direct Practice with Clients. 3rd Annual 
Judy Levy Ethics Workshop, sponsored by Social Work at Kennedy Krieger Institute, Conference Center at Sheppard 
Pratt, 6501 N. Charles St., Towson, MD. For more information, contact Linda Friend at 443-923-2802, friend@kenne-
dykrieger.org.
APRIL
5 (12N-1PM Webinar) 
Should Parents Be Allowed to Test Their Children for Adult-Onset Conditions? Debate between geneticist and bioethi-
cist Kelly Ormond and philosopher Rosamond Rhodes. Sponsored by Children’s Mercy Bioethics Center. For more 
information and to register, visit http://www.childrensmercy.org/cmbc/.
18 
Palliative Care: Healing the Mind, Body and Spirit of Patients and Families Experiencing Serious Illness. Sponsored by 
Stella Maris, in the Stella Maris Auditorium, 2300 Dulaney Valley Road, Timonium, MD. For more information, call 
410-252-4500, ext. 7208.
18 (4PM) 
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Penn-
sylvania, 3401 Market Street, Suite 320, Philadelphia, PA, Joan Karnell Cancer Center (Room TBD). Topic: Pain & 
Supportive Care Program Team.
25-26 
Clinical Ethics Case Consultation Workshop, sponsored by MedStar Washington Hospital Center. For more information, 
contact O. Mary Tawose at Olubukunola.M.Tawose@medstar.net.
MAY
2-3 
Intensive Workshop in Healthcare Ethics; Special Topic: “Relating to Cancer.” Sponsored by the Division of Medical 
Humanities, College of Medicine, University of Arkansas. For more information, visit http://www.uams.edu/humani-
ties/. 
9-10 
Bedside, Boardroom, and Boulevard: Health Care Ethics at the Intersections. Sponsored by the Colorado Healthcare 
Ethics Forum, Stonebrook Manor Event Center and Gardens in Thornton, Colorado.  For more information, visit http://
coloradoethicsforum.org/. 
13-14 
Intensive Course in Bioethics Consultation Skills, sponsored by the bioethics consultation service at the Montefiore 
Medical Center and Albert Einstein College of Medicine, New York, NY. For more information, visit http://www.ein-
stein.yu.edu/masters-in-bioethics.
14 (9A-12:15PM) 
Becoming Fully Alive Through Working with the Dying. Sponsored by Stella Maris, in the Stella Maris Auditorium, 
2300 Dulaney Valley Road, Timonium, MD. For more information, call 410-252-4500, ext. 7208.
16 (4PM) 
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Pennsyl-
vania, 3401 Market Street, Suite 320, Philadelphia, PA, CHOP Abramson Building Room 123-AB featuring the CHOP 
Pediatric Advanced Care Team (PACT).
16-17 
Palliative Care and Ethics Conference. Sponsored by the Center for Healthcare Ethics at Duquesne University, Pitts-
burgh, PA. For more information, visit http://www.duq.edu/academics/schools/liberal-arts/centers/center-for-healthcare-
ethics.
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22-23 
Medical Humanities in Clinical Practice, Medical Humanities Consortium’s Eleventh Annual Meeting. Drew University, 
Caspersen School of Graduate Studies, Madison, NJ. For more information, contact Phyllis DeJesse at pdejesse@drew.edu.
28-30 
What Does It Mean to Care? Religious Traditions and Health Professions Today. Sponsored by the Program on Medicine 
and Religion at the University of Chicago, Westin Hotel, Chicago, IL. For more information, visit https://pmr.uchicago.edu/
events/2013-conference. 
JUNE
3-4 
Intensive Course in Bioethics Consultation Skills, sponsored by the bioethics consultation service at the Montefiore Medi-
cal Center and Albert Einstein College of Medicine, New York, NY. For more information, visit http://www.einstein.yu.edu/
masters-in-bioethics. 
3-7 
Bioethics: More Relevant Than Ever. Intensive Bioethics Course sponsored by the Kennedy Institute of Ethics, George-
town, MD. For more information, visit http://kennedyinstitute.georgetown.edu/programs/ibc.cfm.
12-14 
Harvard Clinical Bioethics Course, Sponsored by the Harvard Medical School Division of Medical Ethics and  Department 
of Continuing Education. For more information, visit http://medethics.med.harvard.edu/education/bioethics/.
19-21 
Working Together to Shape the Future: 3rd Cambridge Consortium for Bioethics Education, Sponsored by Cambridge Uni-
versity Press. Reid Hall, Paris France. For more information, visit cambridgebioethics.com.
20 (4PM) 
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Pennsylva-
nia, 3401 Market Street, Suite 320, Philadelphia, PA, PCAM A- CC (conference center) featuring Joshua B. Kayser, MD, 
MPH, Assistant Professor of Clinical Medicine, Division of Pulmonary, Allergy and Critical Care.
The Johns Hopkins Berman Institute of Bioethics hosts bioethics seminars on the second and fourth 
Monday of each month from 12:15 PM to 1:30 PM. Lunch is provided. To receive emails of seminar 
speakers or for more information, contact Tracie Ugamato at tugamato@jhu.edu, 410-614-5550.
The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by 
the Law and Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose 
of MHECN is to facilitate and enhance ethical reflection in all aspects of decision making in health care settings 
by supporting and providing informational and educational resources to ethics committees serving health care 
institutions in the state of Maryland. The Network attempts to achieve this goal by:
   • Serving as a resource to ethics committees as they investigate  
 ethical dilemmas within their institution and as they strive to assist  
 their institution act consistently with its mission statement;
   • Fostering communication and information sharing among Network  
      members;
   • Providing educational programs for ethics committee members, other 
      healthcare providers, and members of the general public on ethical  
 issues in health care; and
   • Conducting research to improve the functioning of ethics committees 
 and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from 
affiliate members who provide additional financial support.
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